{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:32:20Z","timestamp":1776108740748,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2022CXGC020508"],"award-info":[{"award-number":["2022CXGC020508"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025LSW022"],"award-info":[{"award-number":["ZR2025LSW022"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cellsig.2026.112486","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:50:42Z","timestamp":1773391842000},"page":"112486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Geniposide enhances cisplatin sensitivity in non-small cell lung cancer through PUMA-mediated apoptotic pathway"],"prefix":"10.1016","volume":"143","author":[{"given":"Jingjing","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaozu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengchao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2026.112486_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10299","key":"10.1016\/j.cellsig.2026.112486_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112486_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.cellsig.2026.112486_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ctrv.2016.01.003","article-title":"Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer","volume":"44","author":"Fennell","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112486_bb0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","author":"Araghi","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112486_bb0030","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.21.02528","article-title":"Management of stage III non-small-cell lung cancer: ASCO guideline","volume":"40","author":"Daly","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112486_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: past, present and future","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112486_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137241","article-title":"Can cisplatin therapy be improved? Pathways that can be targeted","volume":"23","author":"Ali","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112486_bb0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2011.03.014","article-title":"Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells","volume":"308","author":"Wohlkoenig","year":"2011","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112486_bb0050","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1515\/jtim-2024-0019","article-title":"Histological transformation in lung adenocarcinoma: insights of mechanisms and therapeutic windows","volume":"12","author":"Tan","year":"2024","journal-title":"J Transl Int Med"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112486_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112486_bb0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112486_bb0065","article-title":"Quantification of promoting efficiency and reducing toxicity of traditional Chinese medicine: a case study of the combination of Tripterygium wilfordii hook. f. and Lysimachia christinae hance in the treatment of lung cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112486_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","article-title":"Natural products in cancer therapy: past, present and future","volume":"11","author":"Huang","year":"2021","journal-title":"Nat. Prod. Bioprospect."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112486_bb0075","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/ptr.70008","article-title":"Potential candidates of natural antioxidants from herbs for treating lung disorders: focus on redox balance and natural products","volume":"39","author":"Chang","year":"2025","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112486_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6020039","article-title":"Plant-derived anticancer agents: lessons from the pharmacology of geniposide and its aglycone, genipin","volume":"6","author":"Habtemariam","year":"2018","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112486_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101689","article-title":"A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product","volume":"22","author":"Shan","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.cellsig.2026.112486_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4925682","article-title":"Diverse pharmacological activities and potential medicinal benefits of geniposide","volume":"2019","author":"Zhou","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.cellsig.2026.112486_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.phrs.2018.05.007","article-title":"Potential role of genipin in cancer therapy","volume":"133","author":"Shanmugam","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112486_bb0100","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3892\/etm.2022.11642","article-title":"Geniposide inhibits cell proliferation and migration in human oral squamous carcinoma cells via AMPK and JNK signaling pathways","volume":"24","author":"Bai","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112486_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051069","article-title":"Lactobacillus casei strain Shirota enhances the in vitro antiproliferative effect of geniposide in human oral squamous carcinoma HSC-3 cells","volume":"23","author":"Qian","year":"2018","journal-title":"Molecules"},{"issue":"17","key":"10.1016\/j.cellsig.2026.112486_bb0110","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.7150\/ijms.51329","article-title":"Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5\/miR-27b-3p\/MET axis","volume":"17","author":"Hu","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112486_bb0115","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10528-025-11030-5","article-title":"Geniposide inhibits non-small cell lung cancer by regulating proliferation, apoptosis, invasion, migration, epithelial-mesenchymal transition, and cancer stem-like cell property via Wnt\/\u03b2-catenin pathway","volume":"64","author":"He","year":"2026","journal-title":"Biochem. Genet."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112486_bb0120","first-page":"2957","article-title":"Medicinal supplement genipin induces p53 and Bax-dependent apoptosis in colon cancer cells","volume":"16","author":"Ye","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112486_bb0125","first-page":"2619","article-title":"Genipin inhibits the growth of human bladder cancer cells via inactivation of PI3K\/Akt signaling","volume":"15","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112486_bb0130","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/s12885-019-5957-x","article-title":"Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3\/mcl-1 pathway in gastric cancer","volume":"19","author":"Jo","year":"2019","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112486_bb0135","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026096","article-title":"Genome stability requires p53","volume":"6","author":"Eischen","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112486_bb0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","article-title":"PUMA, a novel proapoptotic gene, is induced by p53","volume":"7","author":"Nakano","year":"2001","journal-title":"Mol. Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2026.112486_bb0145","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/onc.2009.45","article-title":"PUMA, a potent killer with or without p53","volume":"27 Suppl 1","author":"Yu","year":"2008","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112486_bb0150","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s10495-015-1127-z","article-title":"PUMA-mediated mitochondrial apoptotic disruption by hypoxic postconditioning","volume":"20","author":"Li","year":"2015","journal-title":"Apoptosis"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112486_bb0155","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/cdd.2009.28","article-title":"PUMA- and Bax-induced autophagy contributes to apoptosis","volume":"16","author":"Yee","year":"2009","journal-title":"Cell Death Differ."},{"issue":"5\u20136","key":"10.1016\/j.cellsig.2026.112486_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10495-021-01667-z","article-title":"The role of P53 up-regulated modulator of apoptosis (PUMA) in ovarian development, cardiovascular and neurodegenerative diseases","volume":"26","author":"Li","year":"2021","journal-title":"Apoptosis"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112486_bb0165","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-05-2429","article-title":"PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation","volume":"12","author":"Yu","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112486_bb0170","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41419-025-07782-y","article-title":"PUMA reduces FASN ubiquitination to promote lipid accumulation and tumor progression in human clear cell renal cell carcinoma","volume":"16","author":"Luo","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112486_bb0175","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/1535-7163.MCT-23-0162","article-title":"PUMA\/RIP3 mediates chemotherapy response via necroptosis and local immune activation in colorectal cancer","volume":"23","author":"Chen","year":"2024","journal-title":"Mol. Cancer Ther."},{"issue":"11\u221212","key":"10.1016\/j.cellsig.2026.112486_bb0180","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2119\/molmed.2011.00176","article-title":"The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1","volume":"17","author":"Yuan","year":"2011","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112486_bb0185","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genom. Proteom. Bioinforma."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112486_bb0190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12967-025-06525-z","article-title":"Innovative evaluation of selinexor and JQ1 synergy in leukemia therapy via C-MYC inhibition","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112486_bb0195","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112486_bb0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/mr-2023-0058","article-title":"Nanotechnology-based delivery systems to overcome drug resistance in cancer","volume":"4","author":"Patel","year":"2024","journal-title":"Med. Rev. (2021)"},{"key":"10.1016\/j.cellsig.2026.112486_bb0205","article-title":"The drug-resistance mechanisms of five platinum-based antitumor agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112486_bb0210","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-020-03144-y","article-title":"Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance","volume":"11","author":"Kapoor","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112486_bb0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1515\/mr-2024-0076","article-title":"Target discovery-directed pharmacological mechanism elucidation of bioactive natural products","volume":"5","author":"Zhen","year":"2025","journal-title":"Med. Rev. (2021)"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112486_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47090786","article-title":"Geniposide inhibits oral squamous cell carcinoma by regulating PI3K-Akt Signaling-mediated apoptosis: a multi-method validation study","volume":"47","author":"Wang","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112486_bb0225","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1142\/S0192415X25500600","article-title":"Geniposide suppresses tumor progression through DUOX1-mediated ferroptosis in hepatocellular carcinoma","volume":"53","author":"Luo","year":"2025","journal-title":"Am. J. Chin. Med."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112486_bb0230","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1111\/bph.15046","article-title":"Direct inhibition of the TLR4\/MyD88 pathway by geniposide suppresses HIF-1\u03b1-independent VEGF expression and angiogenesis in hepatocellular carcinoma","volume":"177","author":"Zhang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112486_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110077","volume":"118","author":"Kimura","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112486_bb0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15586\/qas.v14i1.1016","article-title":"Geniposide inhibits non-small cell lung cancer cell migration and angiogenesis by regulating PPAR\u03b3\/VEGF-A pathway","volume":"14","author":"Jiang","year":"2022","journal-title":"Quality Assurance Safety Crops Foods"},{"key":"10.1016\/j.cellsig.2026.112486_bb0245","doi-asserted-by":"crossref","first-page":"1422686","DOI":"10.3389\/fphar.2024.1422686","article-title":"Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality","volume":"15","author":"Pang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112486_bb0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112486_bb0255","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","article-title":"Mechanisms of BCL-2 family proteins in mitochondrial apoptosis","volume":"24","author":"Czabotar","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12 Pt 1","key":"10.1016\/j.cellsig.2026.112486_bb0260","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1158\/1535-7163.MCT-07-0265","article-title":"Chemosensitization of head and neck cancer cells by PUMA","volume":"6","author":"Sun","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112486_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108164","article-title":"Discovery of a tribenzophenazine analog for binding to the KRAS mRNA G-quadruplex structures in the cisplatin-resistant non-small cell lung cancer","volume":"301","author":"Wang","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2026.112486_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108692","article-title":"Chelerythrine may bind to KRAS mRNA G-quadruplex in the cisplatin-resistant non-small cell lung cancer cells","volume":"163","author":"Zhou","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112486_bb0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1515\/mr-2025-0052","article-title":"G protein-coupled receptors as novel therapeutic targets in non-small-cell lung cancer","volume":"5","author":"Ma","year":"2025","journal-title":"Med. Rev. (2021)"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112486_bb0280","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2025.01.014","article-title":"Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: a multicenter phase 2 PLATINUM trial","volume":"43","author":"Xu","year":"2025","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112486_bb0285","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/14737159.2022.2125802","article-title":"The prognostic and clinical value of p53 upregulated modulator of apoptosis expression in solid tumors: a meta-analysis and TCGA data review","volume":"22","author":"Gao","year":"2022","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"38","key":"10.1016\/j.cellsig.2026.112486_bb0290","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/onc.2017.249","article-title":"FHIT loss confers cisplatin resistance in lung cancer via the AKT\/NF-\u03baB\/slug-mediated PUMA reduction","volume":"36","author":"Wu","year":"2017","journal-title":"Oncogene"},{"issue":"35","key":"10.1016\/j.cellsig.2026.112486_bb0295","doi-asserted-by":"crossref","first-page":"56338","DOI":"10.18632\/oncotarget.10841","article-title":"EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112486_bb0300","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.euroneuro.2015.04.009","article-title":"Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis","volume":"25","author":"Cai","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.cellsig.2026.112486_bb0305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jep.2016.12.022","article-title":"Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats","volume":"196","author":"Wang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cellsig.2026.112486_bb0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejphar.2015.09.029","article-title":"Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson\u2019s disease","volume":"768","author":"Chen","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112486_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155799","article-title":"Geniposide dosage and administration time: balancing therapeutic benefits and adverse reactions in liver disease treatment","volume":"132","author":"Qiu","year":"2024","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112486_bb0320","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1515\/mr-2024-0021","article-title":"Unleashing the potential: super-resolution microscopy as the key to advanced mitochondrial research","volume":"4","author":"Li","year":"2024","journal-title":"Med. Rev. (2021)"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:02:03Z","timestamp":1776103323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826001373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"alternative-id":["S0898656826001373"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112486","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geniposide enhances cisplatin sensitivity in non-small cell lung cancer through PUMA-mediated apoptotic pathway","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112486"}}